癌症研究档案

  • 国际标准期刊号: 2254-6081
  • 期刊 h 指数: 13
  • 期刊引用分数: 3.58
  • 期刊影响因子: 3.12
索引于
  • 中国知网(CNKI)
  • 引用因子
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

Cancer Therapy and Beyond: Current Standing, Drug Candidates, Associated Risks and Progress in Targeted Medical Specialty

Valentine falco

Cancer may be a heterogeneous and complex malady during which a series of genomic/molecular alterations cause the uncontrolled growth and proliferation of the cells, inflicting a speedy increase in tissue mass within the affected components of the body. Beneath traditional conditions, a cell gets signals to die to come after the organism with a young and healthier cell. Cancer cells grow victimisation the body's element and supplements, depriving different cells of normal supplements and growth factors. These cells will flip the microenvironment in their favor, deceive the system of the body, and might exploit the physiology of different cells to accommodate their wants. Via a number of the biomarkers that square measure presently been accustomed sight cancer embody human canal super molecule four (HE4), carcinoembryonic matter (CEA), legumain, mesothelin, osteopontin, and sustenance E-binding protein.

An embarrassment of anti-cancer medication and natural medicative compounds are devised over the years, which might suppress growth through various mechanisms. A number of the drugs/compounds work on crucial cellular enzymes, whereas others could alter cell metabolism. They need conjointly shown the potential to interfere with some essential cellular processes, e.g., programmed cell death/apoptosis, drug resistance, DNA damage, polymer replication, or immune reactions. These medications have distinct modes of action and property for multiple cancer types but, refined alteration to their chemical structure may get rid of their anti-cancer efficiency.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证